<img alt="" src="https://secure.soil5hear.com/223550.png" style="display:none;">
Select Models

CDX

SU-DHL-6

Tumor indication

Lymphoma

Tumor subtype

DLBCL (GCB)

Description

SU-DHL-6 (Lymphoma CDX Model) 

The SU-DHL-6 cell line was derived from a diffuse large B-cell lymphoma (DLBCL). It represents aggressive B-cell malignancies. SU-DHL-6 is commonly used in hematology research and therapeutic testing. Its consistent biology supports translational lymphoma studies. 

Key Features: 

  • Derived from diffuse large B-cell lymphoma. 
  • Aggressive B-cell lymphoma line. 
  • Suspension culture growth. 
  • Tumorigenic in xenografts. 

Applications: 
SU-DHL-6 supports evaluation of targeted therapies for DLBCL. It is used in biomarker development and signaling pathway studies. Researchers employ it in resistance and drug screening research. Its reproducibility makes it valuable for translational pipelines.

Details

Tumor indication
Lymphoma
Tumor subtype
DLBCL (GCB)
Organism
Human
Mouse sex
Female
Lumin data
Proteomics, RNA-Seq, WES

Mutated genes

Select a gene to see the variants recorded for this line.

ARID1A EZH2 TP53

Request this cell line